Worley, Paul F.
and the Alzheimer’s Disease Sequencing Project Phenotype Harmonization Consortium (ADSP-PHC) Analyst Team
38 papers on CoChatORCID 0000-0002-5086-614X
Most cited papers
- Verified
The neuronal pentraxin Nptx2 regulates complement activity and restrains microglia-mediated synapse loss in neurodegeneration
Zhou, J., Wade, S. D., Graykowski, D., Xiao, M.-F., Zhao, B., Giannini, L. A. A., Hanson, J. E., van Swieten, J. C., Sheng, M., Worley, P. F., et al. (2023) · Science Translational Medicine
Neuroinflammation and Neurodegeneration MechanismsComplement system in diseases
Cited by 152
- Verified
Activity-regulated cytoskeletal-associated protein is localized to recently activated excitatory synapses
Moga, D. E., Calhoun, M. E., Chowdhury, A., Worley, P., Morrison, J. H., & Shapiro, M. L. (2004) · Neuroscience
Neuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms
Cited by 134
- Verified
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
Galasko, D., Xiao, M., Xu, D., Smirnov, D., Salmon, D. P., Dewit, N., Vanbrabant, J., Jacobs, D., Vanderstichele, H., Vanmechelen, E., et al. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 133
- Verified
mGluR1/5-Dependent Long-Term Depression Requires the Regulated Ectodomain Cleavage of Neuronal Pentraxin NPR by TACE
Cho, R. W., Park, J. M., Wolff, S. B. E., Xu, D., Hopf, C., Kim, J.-A., Reddy, R. C., Petralia, R. S., Perin, M. S., Linden, D. J., et al. (2008) · Neuron
Neuroscience and Neuropharmacology ResearchGenetics and Neurodevelopmental Disorders
Cited by 125
- Verified
Neuronal pentraxin 2: a synapse-derived CSF biomarker in genetic frontotemporal dementia
van der Ende, E. L., Xiao, M., Xu, D., Poos, J. M., Panman, J. L., Jiskoot, L. C., Meeter, L. H., Dopper, E. G., Papma, J. M., Heller, C., et al. (2020) · Journal of Neurology, Neurosurgery & Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 94
- Verified
Identification of novel cerebrospinal fluid biomarker candidates for dementia with Lewy bodies: a proteomic approach
van Steenoven, I., Koel-Simmelink, M. J. A., Vergouw, L. J. M., Tijms, B. M., Piersma, S. R., Pham, T. V., Bridel, C., Ferri, G.-L., Cocco, C., Noli, B., et al. (2020) · Molecular Neurodegeneration
Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment Research
Cited by 83
- Verified
White matter abnormalities and cognition in aging and Alzheimer disease
Peter, C., Sathe, A., Shashikumar, N., Pechman, K. R., Workmeister, A. W., Jackson, T. B., Huo, Y., Mukherjee, S., Mez, J., Dumitrescu, L. C., et al. (2025) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAdvanced Neuroimaging Techniques and Applications
Cited by 59
- Verified
Definition of a Bidirectional Activity-Dependent Pathway Involving BDNF and Narp
Mariga, A., Glaser, J., Mathias, L., Xu, D., Xiao, M., Worley, P., Ninan, I., & Chao, M. V. (2015) · Cell Reports
Neuroscience and Neuropharmacology ResearchNerve injury and regeneration
Cited by 45
- Verified
Prominent Narp expression in projection pathways and terminal fields
Reti, I. M., Reddy, R., Worley, P. F., & Baraban, J. M. (2002) · Journal of Neurochemistry
Neuroscience and Neuropharmacology ResearchBiomarkers in Disease Mechanisms
Cited by 42
- Verified
Pathologically Decreased CSF Levels of Synaptic Marker NPTX2 in DLB Are Correlated with Levels of Alpha-Synuclein and VGF
Boiten, W., van Steenoven, I., Xiao, M.-F., Worley, P., Noli, B., Cocco, C., Ferri, G.-L., Lemstra, A., & Teunissen, C. (2020) · Cells
Dementia and Cognitive Impairment ResearchParkinson's Disease Mechanisms and Treatments
Cited by 42
- Verified
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer’s disease-related inhibitory circuit dysfunction in adults with Down syndrome
Belbin, O., Xiao, M.-F., Xu, D., Carmona-Iragui, M., Pegueroles, J., Benejam, B., Videla, L., Fernández, S., Barroeta, I., Nuñez-Llaves, R., et al. (2020) · Molecular Neurodegeneration
Down syndrome and intellectual disability researchDementia and Cognitive Impairment Research
Cited by 39
- Verified
The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc
Greer, P. L., Hanayama, R., Bloodgood, B. L., Mardinly, A. R., Lipton, D. M., Flavell, S. W., Kim, T.-K., Griffith, E. C., Waldon, Z., Maehr, R., et al. (2010) · Cell
Genetics and Neurodevelopmental DisordersNeuroscience and Neuropharmacology Research
Cited by 30
- Verified
Pentraxins coordinate excitatory synapse maturation and circuit integration of parvalbumin interneurons
Pelkey, K. A., Barksdale, E., Craig, M. T., Yuan, X., Sukumaran, M., Vargish, G. A., Mitchell, R. M., Wyeth, M. S., Petralia, R. S., Chittajallu, R., et al. (2016) · Neuron
Neuroscience and Neuropharmacology ResearchNeurogenesis and neuroplasticity mechanisms
Cited by 22
- Verified
CYFIP1 Dosages Exhibit Divergent Behavioral Impact via Diametric Regulation of NMDA Receptor Complex Translation in Mouse Models of Psychiatric Disorders
Kim, N.-S., Ringeling, F. R., Zhou, Y., Nguyen, H. N., Temme, S. J., Lin, Y.-T., Eacker, S., Dawson, V. L., Dawson, T. M., Xiao, B., et al. (2022) · Biological Psychiatry
Genetics and Neurodevelopmental DisordersGenomic variations and chromosomal abnormalities
Cited by 15
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free